TY - JOUR
T1 - This is mine, this is for me
T2 - Preexposure prophylaxis as a source of resilience among women in Eswatini
AU - Bärnighausen, Kate E.
AU - Matse, Sindy
AU - Kennedy, Caitlin E.
AU - Lejeune, Charlotte L.
AU - Hughey, Allison B.
AU - Hettema, Anita
AU - Bärnighausen, Till W.
AU - McMahon, Shannon A.
N1 - Funding Information:
Bob L Herd Foundation and the Alexander von Humboldt Foundation
Funding Information:
Funding for this research was received from the Bob L Herd Foundation and the Alexander von Humboldt Foundation.
Publisher Copyright:
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Objective: To understand the relationship between HIV preexposure prophylaxis (PrEP) and resilience among Emaswati women. Design: A qualitative study using semistructured in-depth interviews. Methods: We interviewed 24 women who recently initiated PrEP at one of six publicsector primary-care clinics participating in a government demonstration project for PrEP for the general population, as well as 30 PrEP stakeholders from HIV policy, implementation and donor sectors. Results: PrEP clients and stakeholders described an environment marked by high HIV risk. In this context, clients felt PrEP enhanced their resilience through feelings of protection, control over HIV acquisition, choice in relation to when to take PrEP, sexual pleasure and relief from the fear and consequences of HIV infection. Those in serodiscordant relationships described improved partner communication and a shared sense of responsibility for HIV prevention. Both PrEP clients and stakeholders asserted that PrEP marketing and communication should be Emaswati-led and community-owned. Conclusion: PrEP helps women in Eswatini envision longer, healthier and more fulfilled lives. PrEP enhances resilience through several pathways, including self-efficacy, choice, control over HIV infection and relief from the fear of HIV infection. Social marketing and information campaigns should not only focus on PrEP as an HIVprevention method but also emphasize how PrEP has expanded choice, enhanced control and facilitated sexual enjoyment among PrEP clients.
AB - Objective: To understand the relationship between HIV preexposure prophylaxis (PrEP) and resilience among Emaswati women. Design: A qualitative study using semistructured in-depth interviews. Methods: We interviewed 24 women who recently initiated PrEP at one of six publicsector primary-care clinics participating in a government demonstration project for PrEP for the general population, as well as 30 PrEP stakeholders from HIV policy, implementation and donor sectors. Results: PrEP clients and stakeholders described an environment marked by high HIV risk. In this context, clients felt PrEP enhanced their resilience through feelings of protection, control over HIV acquisition, choice in relation to when to take PrEP, sexual pleasure and relief from the fear and consequences of HIV infection. Those in serodiscordant relationships described improved partner communication and a shared sense of responsibility for HIV prevention. Both PrEP clients and stakeholders asserted that PrEP marketing and communication should be Emaswati-led and community-owned. Conclusion: PrEP helps women in Eswatini envision longer, healthier and more fulfilled lives. PrEP enhances resilience through several pathways, including self-efficacy, choice, control over HIV infection and relief from the fear of HIV infection. Social marketing and information campaigns should not only focus on PrEP as an HIVprevention method but also emphasize how PrEP has expanded choice, enhanced control and facilitated sexual enjoyment among PrEP clients.
KW - Eswatini
KW - Hiv
KW - Implementation science
KW - Preexposure prophylaxis
KW - Prevention
KW - Qualitative
KW - Resilience
KW - Swaziland
UR - http://www.scopus.com/inward/record.url?scp=85071281685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071281685&partnerID=8YFLogxK
U2 - 10.1097/QAD.0000000000002178
DO - 10.1097/QAD.0000000000002178
M3 - Article
C2 - 31397722
AN - SCOPUS:85071281685
SN - 0269-9370
VL - 33
SP - S45-S52
JO - AIDS
JF - AIDS
ER -